Squarepoint
LNAI

Squarepoint’s Lunai Bioworks LNAI Stock Holding History

Squarepoint’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-185
Closed -$39.1K – 4544
2024
Q1 		$39.1K Buy
+185
New +$49.9K ﹤0.01% 3893
2022
Q2 		– Sell
-163
Closed -$108K – 3287
2022
Q1 		$108K Buy
+163
New +$86.8K ﹤0.01% 2591
2021
Q1 		– Sell
-256
Closed -$60K – 3526
2020
Q4 		$60K Sell
256
-142
-36% -$35.9K ﹤0.01% 2787
2020
Q3 		$114K Buy
+398
New +$125K ﹤0.01% 2261
2019
Q4 		– Sell
-127
Closed -$56K – 2745
2019
Q3 		$56K Sell
127
-74
-37% -$28.3K ﹤0.01% 2233
2019
Q2 		$73K Buy
+201
New +$98K ﹤0.01% 2259

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Squarepoint's LNAI Position: Q2 2024 in Review

Squarepoint sold out of Lunai Bioworks (LNAI) in Q2 2024, closing a stake of 185 shares — an estimated $39.1K sold.

Squarepoint first reported a position in LNAI in Q2 2019 and held it in 6 quarters. The position peaked at $114K in Q3 2020. 39 funds tracked by Wall St. Rank hold LNAI as of Q2 2024.

  • Squarepoint reported no remaining Lunai Bioworks position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 185 Lunai Bioworks shares in Q2 2024, an estimated $39.1K.
  • Squarepoint first reported a position in Lunai Bioworks in Q2 2019 and held it in 6 quarters.
  • Squarepoint's Lunai Bioworks position peaked at $114K in Q3 2020.
  • 39 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.